Healio Gastroenterology and Liver Disease presents the following reports on the most recent research on inflammatory bowel diseaseThese reports include…READ MORE ›

Small intestine contrast ultrasonographic assessment of mucosal healing can be an effective method to gauge response to anti-TNF therapy among…READ MORE ›

The FDA approved olaparib as maintenance treatment for adults with deleterious or suspected deleterious germline BRCA-mutated metastatic pancreatic cancer, according…READ MORE ›

Patients with inflammatory bowel disease who received intravenous or non-intravenous opioids while in the hospital are more likely to be…READ MORE ›

Assessing bowel wall thickness with intestinal ultrasound can be a helpful tool to monitor therapeutic response in patients with ulcerative…READ MORE ›

Healio Gastroenterology and Liver Disease presents the following reports on the most recent research on the esophagus and GERD.These reports…READ MORE ›

Moving patients to colonoscopy within 24 hours of hospital admission for acute lower gastrointestinal bleeding does not reduce further bleeding…READ MORE ›

Transitioning to Entyvio after achieving induction of remission with calcineurin inhibitor therapy is safe and effective for patients with ulcerative…READ MORE ›

Poxel announced positive safety, tolerability and pharmacokinetic results from a phase 1b multiple ascending dose trial of PXL065, a deuterium-stabilized…READ MORE ›

Patients with inflammatory bowel disease and other immune-mediated diseases treated with anti-TNF alpha who previously had cancer are not at…READ MORE ›